The development and progress of the global CMO API drug market

Custom Synthesis ,The development and progress of the global CMO drug market: The global pharmaceutical market is growing at a steady pace of twice times the world’s economic growth, and according to statistics, global drug sales grew from $387 billion in 2001 to $643 billion in 2006. 2001 Global Drug market sales will reach $7750.895 trillion trillion.

However, international pharmaceutical companies are also facing more and more fierce competition, more and more difficult to maintain the strong growth in business performance. In the face of this dilemma, enterprises can make their non-core, secondary functions and business outsourcing to professional service organizations outside the enterprise, leveraging the expertise and advantages of others to improve the efficiency and competitiveness of enterprises, so as to focus on its core competencies and business, to control operating costs, improve cost effectiveness, reduce risk.

At present, in the CMO raw materials manufacturing field in Europe and the United States and Japan, the technology leader in the general face the pressure of production, environmental protection and human costs, more and more pharmaceutical plants will CMO the production of raw materials to direct procurement or outsourcing production. Foreign pharmaceutical manufacturers need to CMO raw materials and intermediates of about 60% for outsourcing or contract production, this proportion will continue to expand, which for our country’s CMO raw material drug production enterprises to provide a broad market. By 2011, the size of the global pharmaceutical outsourcing industry is expected to exceed $26 billion trillion.